Free Account Opening + AMC Free Demat
Loading...

Paytm IPO vs Tatva Chintan Pharma IPO

Comparision between Paytm IPO and Tatva Chintan Pharma IPO.

IPO Details

Paytm IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tatva Chintan Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Paytm IPO is up to ₹18,300.00 Cr whereas the issue size of the Tatva Chintan Pharma IPO is up to ₹500.00 Cr. The final issue price of Paytm IPO is ₹2,150.00 per share and of Tatva Chintan Pharma IPO is ₹1,083.00 per share.

  Paytm IPO Tatva Chintan Pharma IPO
Face Value ₹1 per share ₹10 per share
Issue Price (Lower) ₹2,080.00 per share ₹1,073.00 per share
Issue Price (Upper) ₹2,150.00 per share ₹1,083.00 per share
Issue Price (Final) ₹2,150.00 per share ₹1,083.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 6 shares 13 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹8,300.00 Cr up to ₹225.00 Cr
OFS Issue Size
OFS Issue Size (Amount) up to ₹10,000.00 Cr up to ₹275.00 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹18,300.00 Cr up to ₹500.00 Cr

IPO Timetable

Paytm IPO opens on Nov 08, 2021, while Tatva Chintan Pharma IPO opens on Jul 16, 2021. The closing date of Paytm IPO and Tatva Chintan Pharma IPO is Nov 10, 2021, and Jul 20, 2021, respectively.

  Paytm IPO Tatva Chintan Pharma IPO
Anchor Bid Date
Issue Open Nov 08, 2021 Jul 16, 2021
Issue Close Nov 10, 2021 Jul 20, 2021
Basis Of Allotment (Tentative) Nov 15, 2021 Jul 26, 2021
Initiation of Refunds (Tentative) Nov 16, 2021 Jul 27, 2021
Credit of Share (Tentative) Nov 17, 2021 Jul 28, 2021
Listing date (Tentative) Nov 18, 2021 Jul 29, 2021
Anchor Lockin End date 1 Dec 15, 2021 Aug 25, 2021
Anchor Lockin End date 2 Feb 13, 2022 Oct 24, 2021

Financials

Paytm IPO P/E ratio is , as compared to Tatva Chintan Pharma IPO P/E ratio of .

  Paytm IPO Tatva Chintan Pharma IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
30-Jun-21 30-Jun-20 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 94,590 102,777 91,513 103,031 87,668
Total Revenue 9,480 6,494 31,868 35,407 35,797
Profit After Tax (3,819) (2,844) (17,010) (29,424) (42,309)
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 3,148.03 2,489.38 1,875.08
Total Revenue 3,062.92 2,646.22 2,068.01
Profit After Tax 522.62 377.89 205.43
Promoter Shareholding (Pre-Issue) 100%
Promoter Shareholding (Post-Issue) 79.17%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Paytm IPO retail investors (RII) are offered 87,98,076 shares while in Tatva Chintan Pharma IPO retail investors are offered 87,98,076 shares. Qualified institutional buyers (QIB) are offered 2,63,94,231 shares in Paytm IPO and 9,31,966 shares in Tatva Chintan Pharma IPO.

  Paytm IPO Tatva Chintan Pharma IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 2,63,94,231 shares 9,31,966 shares
NII 1,31,97,115 shares 6,98,975 shares
RII 87,98,076 shares 16,30,941 shares
Employee 0 shares 0 shares
Others
Total 4,83,89,422 shares 32,61,882 shares

Bids Received (Subscription)

Paytm IPO subscribed 1.89x in total, whereas Tatva Chintan Pharma IPO subscribed 180.36x.

  Paytm IPO Tatva Chintan Pharma IPO
QIB (times) 2.79x 185.23x
NII (times) 0.24x 512.22x
Big NII (times)
Small NII (times)
RII (times) 1.66x 35.35x
Employee (times)
Other (times)
Total (times) 1.89x 180.36x

Comments

Add a public comment...